Mankind Pharma buys rights to Rivotril, deepening central nervous system therapy push
Mankind Pharma buys rights to Rivotril, deepening central nervous system therapy push
Mankind Pharma buys rights to Rivotril, deepening central nervous system therapy push
Sector
HEALTHCARE
News Type
MARKET
Impact Level
LOW
AI Sentiment
NEUTRAL
Published
08 May 2026
📎 Sources
Moneycontrol | https://www.tradingview.com/news/moneycontrol:09f11eadc094b:0-mankind-pharma-buys-rights-to-rivotril-deepening-central-nervous-system-therapy-push/